Medical Equipment

One of the Major Drivers of the Hemostatic Agents Market Is the Rise In Surgical Procedures Fueling The Growth Of The Market Due To Increasing Demand For Bleeding Control In Operative Settings

March 12, 2026March 12, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Forecasted Market Value Of The Hemostatic Agents Market Across 2026–2030?

The hemostatic agents market has demonstrated robust expansion over recent years. It is anticipated to increase from $4.42 billion in 2025 to $4.66 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 5.4%. This growth in the preceding period can be attributed to a limited variety of hemostatic agents, reliance on traditional thrombin and gelatin products, a rising number of surgical procedures, expanding hospital infrastructure, and greater awareness of blood loss management.

The hemostatic agents market size is forecast to show significant expansion in the coming years. It is predicted to reach $5.71 billion in 2030, progressing at a compound annual growth rate (CAGR) of 5.2%. This growth over the forecast period can be attributed to the development of recombinant and sprayable fibrin sealants, an increase in minimally invasive and orthopedic surgeries, growing demand for multi-agent and combination hemostats, broader adoption in plastic and neurosurgery applications, and regulatory emphasis on sterility and biocompatibility. Key trends identified for the forecast period include a rising demand for advanced hemostatic agents in surgical procedures, increasing adoption of combination and multi-agent hemostats, growth in fibrin sealants and biologically derived products, the expansion of hemostats use in trauma and cardiovascular surgeries, and an enhanced focus on safety, sterility, and regulatory compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

Which Market Drivers Are Supporting The Expansion Of The Hemostatic Agents Market?

The projected expansion of the hemostatic agents market is linked to the growing volume of surgical operations anticipated in the future. These operations involve medical interventions carried out by healthcare experts with specific tools to treat, mend, or excise bodily sections for health improvement. This uptick in surgeries primarily stems from a greater incidence of chronic illnesses, frequently necessitating surgical care to handle health concerns and enhance patient recovery. Within surgical settings, hemostatic agents play a crucial role by rapidly controlling hemorrhage, thereby minimizing blood loss and enhancing the clarity of the surgical field for precise procedures. As an illustration, in October 2025, surveillance information from the 2023–24 period, released by the UK Health Security Agency (UKHSA), a UK-based national government public health agency, indicated that 135,619 operations were reported, with 1,276 surgical site infections (SSIs) identified either during hospitalization or upon readmission. This marked an 8.4% rise in reported operations compared to the preceding year. Consequently, the rising volume of surgical interventions is a key stimulant for the expansion of the hemostatic agents market.

What Segmentation Levels Are Considered In The Hemostatic Agents Market?

The hemostatic agents market covered in this report is segmented –

1) By Type: Thrombin-Based Hemostats, Gelatin-Based Hemostats, Collagen-Based Hemostats, Oxidized Regenerated Cellulose-Based Hemostats, Combination Hemostats, Fibrin Sealants, Other Types

2) By Application: Trauma, Cardiovascular Surgery, General Surgery, Plastic Surgery, Orthopedic Surgery, Neurosurgery, Other Applications

3) By End-User: Hospitals, Surgery Centers, Nursing Homes, Other End Users

Subsegments:

1) By Thrombin-Based Hemostats: Bovine Thrombin, Human Thrombin, Poxidized Regenerated Cellulose (Orc)Ine Thrombin, Combined Thrombin Products

2) By Gelatin-Based Hemostats: Absorbable Gelatin Sponges, Gelatin Powder, Gelatin Paste, Gelatin With Thrombin

3) By Collagen-Based Hemostats: Collagen Sponges, Collagen Powder, Collagen With Thrombin, Collagen Sheets Or Patches

4) By Oxidized Regenerated Cellulose-Based Hemostats: Oxidized Regenerated Cellulose (ORC) Pads, Oxidized Regenerated Cellulose (ORC) Mesh, Oxidized Regenerated Cellulose (ORC) Powder, Oxidized Regenerated Cellulose (ORC) With Other Active Agents

5) By Combination Hemostats: Gelatin And Thrombin Combinations, Collagen And Thrombin Combinations, Oxidized Regenerated Cellulose (ORC) And Thrombin Combinations, Multi-Agent Combinations

6) By Fibrin Sealants: Human Plasma-Derived Fibrin Sealants, Recombinant Fibrin Sealants, Sprayable Fibrin Sealants, Liquid Fibrin Sealants, Fibrin Sealants With Antimicrobials

7) By Other Types: Polysaccharide-Based Hemostats, Synthetic Polymer-Based Hemostats, Microfibrillar Collagen Hemostats, Chitosan-Based Hemostats, Calcium-Based Hemostats

What Trends Are Projected To Affect The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are concentrating on developing advanced solutions, such as collagen-based hemostats, to deliver rapid and effective hemostasis and tissue sealing for both open and minimally invasive surgeries. Collagen-based hemostats are hemostatic materials derived from purified collagen, which assist in stopping bleeding by enhancing the body’s natural clotting process at the site of a wound or surgical incision. For instance, in March 2025, Baxter, a US-based healthcare company, launched HEMOPATCH Sealing Hemostat, a collagen-based absorbable pad. This advanced collagen-based pad integrates a dual-action system combining a collagen matrix with an NHS-PEG layer that forms a hydrogel upon contact with moisture, enabling quick sealing of bleeding sites. It provides strong adhesion to wet tissues, making it suitable for both open and minimally invasive surgeries where other agents might be less effective. The patch delivers hemostasis in under two minutes without requiring temperature-controlled storage or special preparation, thereby streamlining surgical procedures. It also naturally dissolves in the body within 6 to 8 weeks and can be stored at room temperature for up to three years, addressing important clinical and storage requirements.

Which Leading Firms Are Contributing To The Growth Of The Hemostatic Agents Market?

Major companies operating in the hemostatic agents market are Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z-Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., Biom’Up SAS.

Read the full hemostatic agents market report here:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

How Is The Hemostatic Agents Market Distributed Across Key Geographic Regions?

North America was the largest region in the hemostatic agents market in 2025. The regions covered in the hemostatic agents market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Hemostatic Agents Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25780&type=smp

Browse Through More Reports Similar to the Global Hemostatic Agents Market 2026, By The Business Research Company

Hemostats Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostats-global-market-report

Hematology Drug Market Report 2026

https://www.thebusinessresearchcompany.com/report/hematology-drug-global-market-report

Hemostasis Diagnostic Devices And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/hemostasis-diagnostic-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795